By the end of the Brexit transition on December 31, when Britain will no longer be a member of the European Union, marijuana patients in the UK will be cut off from marijuana supplies in the Netherlands, the Independent reports.
In a December 15 letter from the UK Department of Health and Social Care (DHSC), the agency advised importers to work with clinics, pharmacies, and prescribers to offer potential alternatives to medical cannabis patients because “dispensing finished cannabis oil (Bedrocan products) in The Netherlands against prescriptions from UK prescribers is no longer an option from 1 January 2021.”
According to the report, about 40 children with severe epilepsy in the UK have been prescribed medical marijuana and obtained marijuana from the European Union.
A spokesman from End Our Pain, a UK based medical marijuana advocacy group, said ending the supply of medical marijuana in the Netherlands was "a matter of life and death for these children". "The government must now act to help these families find solutions," the spokesman added
A spokesman for the Department of health and social care told the Independent that the agency sympathized with patients and said "patients in the UK can use a range of alternative drugs based on marijuana."
Two cannabis-based drugs have been approved in the UK for use in the NHS; however, according to "End Our Pain", officials have only prescribed three prescriptions for the drug since the reform in 2018. Some of these medicines have to be paid about £2,000 a month from the Netherlands charities, forcing families to rely on some of these medicines.